RRS: Cohort Study of Risk Reducing Salpingectomy

Sponsor
University of North Carolina, Chapel Hill (Other)
Overall Status
Completed
CT.gov ID
NCT02165709
Collaborator
Medtronic - MITG (Industry)
18
1
2
15
1.2

Study Details

Study Description

Brief Summary

Women undergoing surgical sterilization will be interested in risk reducing salpingectomy, and surgeons performing the procedure will be able to successfully complete the salpingectomy.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Salpingectomy
  • Procedure: Traditional sterilization
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
18 participants
Allocation:
Non-Randomized
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Cohort Study of Risk Reducing Salpingectomy (RRS) Versus Standard Tubal Sterilization Among Women Who Desire Sterilization
Study Start Date :
Jun 1, 2014
Actual Primary Completion Date :
Aug 1, 2015
Actual Study Completion Date :
Sep 1, 2015

Arms and Interventions

Arm Intervention/Treatment
Experimental: Salpingectomy

Participants will be offered a risk-reducing salpingectomy, and if they choose this options the surgeon will proceed with a salpingectomy.

Procedure: Salpingectomy

Active Comparator: Traditional sterilization

Participants will be offered a risk-reducing salpingectomy, and those that choose a traditional sterilization will be in this treatment arm.

Procedure: Traditional sterilization

Outcome Measures

Primary Outcome Measures

  1. Percent of women accepting RRS [12 months]

    Determination of patient demand/interest in pursuing RRS for sterilization during 12-month study period

Secondary Outcome Measures

  1. Percent of women with successful RRS completion [12 months]

    Feasibility will be defined as number (%) of successful RRS completion when intended

Eligibility Criteria

Criteria

Ages Eligible for Study:
35 Years to 60 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Women > 35 years requesting sterilization as interval procedure OR at time of cesarean delivery

  • At least one living child

  • English or Spanish speaking

  • Sterilization planned as interval (laparoscopic) procedure via Family Planning Clinic services or at time of delivery

  • Delivery by cesarean section (planned or following labor)

Exclusion Criteria:
  • Age < 30

  • Medical complications that increase risk for surgical bleeding (e.g. Idiopathic thrombocytopenic purpura (ITP); von Willebrand disease (vWD); need for prophylactic or therapeutic anticoagulation)

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of North Carolina Hosptials Chapel Hill North Carolina United States 27599

Sponsors and Collaborators

  • University of North Carolina, Chapel Hill
  • Medtronic - MITG

Investigators

  • Principal Investigator: Matthew L Zerden, MD, MPH, University of North Carolina, Chapel Hill

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University of North Carolina, Chapel Hill
ClinicalTrials.gov Identifier:
NCT02165709
Other Study ID Numbers:
  • 14-0337
First Posted:
Jun 17, 2014
Last Update Posted:
Apr 25, 2017
Last Verified:
Apr 1, 2017

Study Results

No Results Posted as of Apr 25, 2017